Please note this application is under active development. If you spot any errors or something isn't working, please contact us at evidence.service@wales.nhs.uk.

Tobacco: preventing uptake, promoting quitting and treating dependence: update [N] Evidence reviews for smoking relapse prevention

National Institute for Health and Care Excellence (2021)

NICE - ISBN: 978-1-4731-4347-0

Evidence Categories

  • Care setting: Healthcare Setting
  • Care setting: Community setting
  • Population group: Adults
  • Population group: Pre existing health condition
  • Population group: Pregnancy/ post-partum
  • Population group: Children & Young adults
  • Intervention: Bupropian
  • Intervention: Multicomponent Interventions
  • Intervention: Electronic Nicotine Delivery System
  • Intervention: Self-Help Materials
  • Intervention: Behaviour Support
  • Intervention: Nicotine Replacement Therapy
  • Intervention: Varenicline
  • Outcome: Smoking cessation
  • Outcome: Smoking Relapse Prevention

Type of Evidence

NICE Underpinning Review

Overview

Several treatments can help smokers make a successful quit attempt, but many of those who initially successfully quit relapse over time. Preventing relapse in people who have quit smoking is important for health benefits to be realised. Several interventions have been proposed to help prevent relapse. This review aims to identify which behavioural or pharmacotherapy interventions are most effective at preventing a relapse in those who have quit smoking recently, defined as at any point in the past.

There is no clear definition of a relapse prevention intervention distinct from extended cessation treatment. In principle, resuming smoking any time after a quit date may be defined as a relapse. Relapse prevention is often, however, intended to refer to preventing relapse after an acute treatment phase is successfully completed. Both types of relapse – at any point after a quit date, and after successful completion of a treatment phase – are included in this review.

This review was completed by the Cochrane Tobacco Addiction Group (TAG) in October 2019 for NICE (Livingstone-Banks et al., 2019)a . Throughout, figures and sections of text have been taken directly from the Cochrane work, or had minor amendments to wording, and are presented here in the standard NICE format.

Recommendations

This evidence review supports recommendations 1.17.1 to 1.17.2, 1.17.6 to 1.17.7, 1.22.1 to 1.22.2, and the research recommendations on relapse prevention and relapse prevention after enforced, temporary quit. Other evidence supporting these recommendations can be found in the evidence reviews on cessation and harm-reduction treatments (review K).

Also In This Category